Biotalys Submits First Protein-Based Biocontrol Registration Package to the EPA
GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Today, Biotalys NV, a transformative food and crop protection company, announces that it has submitted its first protein-based biocontrol, Evoca™, to the Environmental Protection Agency (EPA) in the United States for approval. Pending EPA registration, this biocontrol will offer U.S. fruit and vegetable growers a new way to combat major diseases to maximize yields and extend the shelf life after harvest of produce with substantially lower residues.
“Biotalys is thrilled to have begun the EPA registration process for its first product. While Evoca targets diseases like Botrytis cinerea and powdery mildew, we are leveraging the flexibility of our technology platform to advance a broad pipeline of products with new modes of action that will safely and reliably address key crop pests and diseases across the food value chain,” commented Luc Maertens, COO of Biotalys.
Evoca will help growers effectively control key pathogens in the field, as well as in the food value chain to protect fruits and vegetables post harvest, extending shelf life and reducing decay and food loss. With its new mode of action and favourable safety profile, Evoca provides growers with additional rotational options to manage resistance in a more sustainable way.
The submission follows Biotalys’ successful completion of an extensive field product development program and regulatory studies on Evoca. More than 200 field and greenhouse trials globally demonstrated high consistency in effective control of key pathogens in fruit and vegetables crops. With this submission and pending regulatory approvals, Biotalys is on track to introduce Evoca to select regions in the U.S. market in late 2022.
Biotalys will proceed with international registrations on its own, maintaining full ownership of all rights. Aligned with the go-to-market strategy for Evoca, the submission in the United States will be followed by a submission in the European Union. Major agricultural markets in Latin America and Asia are in scope for future registrations.
Evoca™: Pending Registration. This product is not currently registered for sale or use in the United States and is not being offered for sale.
Biotalys is a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on its groundbreaking technology platform, Biotalys has developed a broad pipeline of effective and safe candidate products that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Combining the high-performance characteristics and consistency of chemicals with the clean safety profile of biologicals, Biotalys goal is to provide ideal crop protection agents for both pre- and post-harvest applications. Based in the biotech cluster in Ghent, Belgium, Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has raised €61 million ($66m USD) to date from specialist international investors. More information can be found on www.biotalys.com.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Savaria (Sweden) completes the Offer to the shareholders in Handicare and extends the acceptance period4.3.2021 23:00:00 CET | Press release
THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE AND IN THE OFFER DOCUMENT PUBLISHED ON SAVARIA (SWEDEN)’S WEBSITE (WWW.NORDIC-OFFER.COM). STOCKHOLM, Sweden, March 04, 2021 (GLOBE NEWSWIRE) -- On 27 January 2021, Savaria (Sweden) AB1 (“Savaria (Sweden)”), a company wholly owned by Savaria Corporation2 (“Savaria”), announced a recommended cash offer to the shareholders of Handicare Group AB (“Handicare”) to tender
Savaria (Sweden) fullföljer Erbjudandet till aktieägarna i Handicare och förlänger acceptperioden4.3.2021 23:00:00 CET | Pressemelding
DETTA PRESSMEDDELANDE UTGÖR INTE ETT ERBJUDANDE, VARKEN DIREKT ELLER INDIREKT, I AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR ETT ERBJUDANDE ENLIGT LAGAR OCH REGLER I SÅDAN RELEVANT JURISDIKTION SKULLE VARA FÖRBJUDET ENLIGT TILLÄMPLIG LAG. AKTIEÄGARE SOM INTE ÄR BOSATTA I SVERIGE SOM ÖNSKAR ACCEPTERA ERBJUDANDET (DEFINIERAT NEDAN) MÅSTE GENOMFÖRA NÄRMARE UNDERSÖKNINGAR AVSEENDE TILLÄMPLIG LAGSTIFTNING OCH MÖJLIGA SKATTEKONSEKVENSER. AKTIEÄGARE HÄNVISAS TILL DE ERBJUDANDERESTRIKTIONER SOM FRAMGÅR AV AVSNITTET ”VIKTIG INFORMATION” I SLUTET AV DETTA PRESSMEDDELANDE OCH AV DEN ERBJUDANDEHANDLING SOM HAR PUBLICERATS PÅ SAVARIA (SWEDEN):S HEMSIDA (WWW.NORDIC-OFFER.COM). STOCKHOLM, Sverige, March 04, 2021 (GLOBE NEWSWIRE) -- Den 27 januari 2021 offentliggjorde Savaria (Sweden) AB1 (“Savaria (Sweden)”), ett bolag helägt av Savaria Corporation2 (“Savaria”), ett rekommenderat kontanterbjudande till aktieägarna i Handicare Gr
MANDATORY NOTIFICATION OF TRADE - OPTIONS4.3.2021 22:51:21 CET | Press release
Reference is made to the announcement on 22 May 2018, in which Hexagon Composites ASA (the "Company") announced the grant of 1,200,000 share options to employees under its employee share option program, each at a strike price of NOK 20.85 per share. Following the distribution of 15% of the shares in Hexagon Purus AS as dividend in kind on 14 December 2020, the strike price has been adjusted by NOK 4.095 to "make whole" the 2018 options holders. The adjusted strike price is NOK 16.755 per share. Of the 1,200,000 options, 800,000 options were granted to senior executives and managers listed as primary insiders. The options may be exercised in part or in full within three weeks following the official announcement of the financial results for the fourth quarter of 2020, first quarter of 2021 and second quarter of 2021. The Company has offered to settle the economic value of the options by delivery of shares held in treasury. The table below shows the movements of the primary insider accoun
2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States4.3.2021 22:00:00 CET | Press release
► Publication of positive topline results from the NATIVE Phase IIb clinical trial evaluating lanifibranor in NASH and decision to move into pivotal Phase III development ► Breakthrough Therapy Designation granted to lanifibranor in NASH by the U.S. Food and Drug Administration (FDA) ► Finalization of Phase III clinical trial design with lanifibranor in NASH following end-of-phase II meeting with the FDA and receipt of Scientific Advice letter from the European Medicines Agency (EMA) ► Expansion into the United States with appointment of Dr. Michael Cooreman, M.D., as Chief Medical Officer and opening of U.S. subsidiary ► Announcement of timeline for Phase III clinical trial evaluating lanifibranor in NASH ► Confirmation by the FDA that the toxicology package regarding lanifibranor is complete and acceptable to support the filing of a New Drug Application (NDA) for the treatment of NASH and improvement of liver fibrosis ► Completion of World Health Organization’s (WHO) International No
Nokia has filed its Annual Report on Form 20-F for 2020 and published its Nokia in 2020 Annual Report4.3.2021 22:00:00 CET | Press release
Nokia has filed its Annual Report on Form 20-F for 2020 and published its Nokia in 2020 Annual Report Nokia Corporation Stock Exchange Release March 4, 2021 at 23:00 EET Nokia has filed its Annual Report on Form 20-F for 2020 with the U.S. Securities and Exchange Commission and published its Nokia in 2020 Annual Report. Espoo, Finland – Nokia has today filed its Annual Report on Form 20-F for 2020 with the U.S. Securities and Exchange Commission. Additionally, Nokia has published its Nokia in 2020 Annual Report, which includes audited financial statements, the annual review by the Board of Directors, Nokia’s corporate governance statement and the Remuneration Report for the governing bodies for 2020. The Annual Report on Form 20-F and Nokia in 2020 Annual Report will be available in PDF format at www.nokia.com/about-us/investors/reports-filings, along with Nokia’s past quarterly and annual financial reports. Shareholders may request a hard copy of the reports free of charge through Nok
Appellate Court Hands Momentous Victory to TriMax Over Wickfire4.3.2021 21:35:30 CET | Press release
The Fifth Circuit Court of Appeals issued a decisive ruling that TriMax Media committed no legal violations against Wickfire, L.L.C., while recognizing a jury’s finding that Wickfire intentionally interfered with TriMax’s business. DALLAS, March 04, 2021 (GLOBE NEWSWIRE) -- After seven years of litigation, TriMax has triumphed over Wickfire. On February 26, 2021, an Appellate Court issued a paramount ruling that Wickfire lacked any evidence to support its claims against TriMax. The decision was made in the United States Court of Appeals for the Fifth Circuit, Case Number 17-3043040. The Appellate Court’s ruling reversed all monetary damages previously awarded to Wickfire. The lawsuit, originally before the Western District of Texas, Case No. 14-CV-34, centered around Google AdWords Auctions, an online-auction platform where companies like TriMax and Wickfire compete for advertising space. Wickfire asserted innumerable claims against TriMax, but as to each one, Wickfire ultimately faile
Informa Markets Drives Economic Recovery with Safe and Successful Return to the Show Floor4.3.2021 20:52:58 CET | Press release
Informa Markets makes a customer-driven return to live events, driving economic recovery, connection and innovation through a collaborative and foundational approach to safety ORLANDO, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- As industries and economies around the world look for opportunities to rebuild business in the wake of the COVID-19 pandemic, Informa Markets, a global organizer who creates platforms for a wide range of industries to trade, connect and grow, launched MAGIC Pop-Up Orlando from February 9-11 at the Orange County Convention Center. The ‘Pop-Up’, a smaller scale regional version of their keystone fashion event which typically takes place twice-yearly in Las Vegas, Nevada was a comprehensive ‘one-stop-shop’ opportunity for various segments of the fashion industry, one of the many industries hit hard by the pandemic’s devastating economic impact, to discover new brands, safely network with like-minded retailers, and generate much-needed revenue. Informa Markets Fashion